中商官网
研究报告
永创医药（833453）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 111000000.0000 | 9278500.0000 | 9778500.0000 | 7274600.0000 | 71030900.0000 | 41088100.0000 | 29942800.0000 |
| 2014 | 63290300.0000 | 2100800.0000 | 2233000.0000 | 1624200.0000 | 69725500.0000 | 38158400.0000 | 31567100.0000 |
| 2015 | 54824000.0000 | 1802400.0000 | 2284200.0000 | 1911600.0000 | 79421900.0000 | 45943200.0000 | 33478700.0000 |
| 2016 | 75980800.0000 | 2530700.0000 | 4843800.0000 | 4014000.0000 | 76168900.0000 | 38676200.0000 | 37492700.0000 |
| 2017 | 69318500.0000 | 4158100.0000 | 5031400.0000 | 4512300.0000 | 76670500.0000 | 34665500.0000 | 42005000.0000 |
| 2018 | 146000000.0000 | 37506300.0000 | 37318900.0000 | 32262800.0000 | 104000000.0000 | 29632300.0000 | 74267700.0000 |
| 2019 | 201000000.0000 | 51337200.0000 | 51217200.0000 | 43730300.0000 | 136000000.0000 | 56349100.0000 | 79664800.0000 |
| 2020 | 170000000.0000 | 55653700.0000 | 50277200.0000 | 43430300.0000 | 136000000.0000 | 41098900.0000 | 94434700.0000 |
| 2021 | 178000000.0000 | 47529100.0000 | 47411000.0000 | 37479100.0000 | 151000000.0000 | 66824800.0000 | 84586300.0000 |
| 2022 | 278000000.0000 | 62270600.0000 | 62068400.0000 | 54050800.0000 | 210000000.0000 | 91633300.0000 | 118000000.0000 |
| 2023 | 303000000.0000 | 64406300.0000 | 64392800.0000 | 56124300.0000 | 196000000.0000 | 31990300.0000 | 164000000.0000 |
| 2024 | 290000000.0000 | 79337900.0000 | 78374700.0000 | 64795900.0000 | 217000000.0000 | 35158500.0000 | 182000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 8.11 | 8.81 | 13.77 | 27.6500 | 5.9700 | 10.86 | 1.56 |
| 2014 | 3.32 | 3.53 | 3.20 | 5.2800 | 2.9000 | 6.25 | 0.91 |
| 2015 | 3.29 | 4.17 | 2.88 | 5.8800 | 2.4500 | 4.00 | 0.69 |
| 2016 | 3.33 | 6.38 | 6.36 | 11.3100 | 3.8100 | 4.61 | 1.00 |
| 2017 | 6.00 | 7.26 | 6.56 | 11.3500 | 2.4100 | 5.94 | 0.90 |
| 2018 | 25.34 | 25.56 | 35.88 | 55.4900 | 3.5300 | 13.06 | 1.40 |
| 2019 | 24.88 | 25.48 | 37.66 | 51.6900 | 3.1100 | 19.80 | 1.48 |
| 2020 | 30.00 | 29.57 | 36.97 | 49.8900 | 2.0500 | 29.75 | 1.25 |
| 2021 | 24.16 | 26.64 | 31.40 | 41.8700 | 2.6600 | 17.84 | 1.18 |
| 2022 | 21.58 | 22.33 | 29.56 | 53.2900 | 4.1700 | 21.60 | 1.32 |
| 2023 | 19.47 | 21.25 | 32.85 | 39.2200 | 3.5100 | 19.70 | 1.55 |
| 2024 | 26.55 | 27.03 | 36.12 | 34.9300 | 2.7400 | 11.37 | 1.34 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 57.85 | 42.15 | 0.9700 | 0.5700 |
| 2014 | 54.73 | 45.27 | 1.0300 | 0.4200 |
| 2015 | 57.85 | 42.15 | 0.9800 | 0.6200 |
| 2016 | 50.78 | 49.22 | 1.1800 | 0.5300 |
| 2017 | 45.21 | 54.79 | 1.1800 | 0.3100 |
| 2018 | 28.49 | 71.41 | 2.0700 | 0.7800 |
| 2019 | 41.43 | 58.58 | 1.8200 | 0.8200 |
| 2020 | 30.22 | 69.44 | 2.2200 | 0.7000 |
| 2021 | 44.25 | 56.02 | 1.5900 | 0.9900 |
| 2022 | 43.63 | 56.19 | 1.7400 | 1.0100 |
| 2023 | 16.32 | 83.67 | 4.4000 | 2.1900 |
| 2024 | 16.20 | 83.87 | 4.6200 | 2.6000 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 102000000.0000 | 4131600.0000 | 5557600.0000 | 1335100.0000 |
| 2014 | 61189600.0000 | 2599800.0000 | 5312700.0000 | 1483700.0000 |
| 2015 | 53021600.0000 | 1962800.0000 | 7523900.0000 | 1599800.0000 |
| 2016 | 73450100.0000 | 3966000.0000 | 7746100.0000 | 1496100.0000 |
| 2017 | 65160400.0000 | 5629300.0000 | 5669600.0000 | 1545100.0000 |
| 2018 | 109000000.0000 | 6261000.0000 | 4990300.0000 | 1348800.0000 |
| 2019 | 151000000.0000 | 15002500.0000 | 7467600.0000 | 826500.0000 |
| 2020 | 119000000.0000 | 1937500.0000 | 6567100.0000 | 899600.0000 |
| 2021 | 135000000.0000 | 1945700.0000 | 8102100.0000 | 328300.0000 |
| 2022 | 218000000.0000 | 2290200.0000 | 6876800.0000 | 1989100.0000 |
| 2023 | 244000000.0000 | 2029400.0000 | 10069700.0000 | -2445500.0000 |
| 2024 | 213000000.0000 | 2291900.0000 | 7903900.0000 | -4000.0000 |